Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

S. Nancey · SciRah

Researcher profile · Semantic Scholar

S. Nancey

Share profile

S. Nancey — researcher profile on SciRah

h-index: 49
Works: 506
Citations: 7,601

Most-cited papers

Long-term outcome of risankizumab in Crohn's disease: a real-world GETAID study.
M. Fumery, B. Caron, X. Hébuterne, R. Altwegg +25 more
2024Clinical Gastroenterology and Hepatology36 citations Open access
Semantic Scholar
Janus kinase (JAK) inhibitor-induced acne in inflammatory bowel disease - an international, multicenter, retrospective cohort study.
S. Honap, M. J. Temido, E. Shakweh, F. Badrulhisham +35 more
2025Clinical Gastroenterology and Hepatology24 citations Open access
Semantic Scholar
Effectiveness and Safety of Upadacitinib Induction Therapy for 223 Patients With Crohn's Disease: A GETAID Multicentre Cohort Study
Nicolas Richard, A. Amiot, P. Seksik, R. Altwegg +16 more
2025Alimentary Pharmacology and Therapeutics14 citations Open access
Semantic Scholar
Peptide‐Based Hydrogel for Nanosystems Encapsulation: the Next Generation of Localized Delivery Systems for the Treatment of Intestinal Inflammations
Valentina Andretto, Annalisa Rosso, Serena Zilio, Jacqueline Sidi-Boumedine +10 more
2024Advanced Healthcare Materials14 citations
Semantic Scholar
Comparative effectiveness of tofacitinib versus upadacitinib for the treatment of acute severe ulcerative colitis.
S. Honap, J. St-Pierre, M. Colwill, Kamal Patel +26 more
2025Clinical Gastroenterology and Hepatology12 citations Open access
Semantic Scholar
Effectiveness and Safety of a Second JAK Inhibitor in Ulcerative Colitis: The J2J Multicentre Study
M. Osty, R. Altwegg, M. Serrero, A. Benezech +27 more
2025Alimentary Pharmacology and Therapeutics12 citations Open access
Semantic Scholar
Physical Activity and IBD: State of Art and Knowledge, Patients and Healthcare Professionals Points of View, A French Multicenter Cross Sectional Study.
L. Derbey, A. Charlois, A. Buisson, X. Roblin +5 more
2024Inflammatory Bowel Diseases12 citations
Semantic Scholar
PErsistence and safety of subcutaneous infliximab 1 year after switch from intravenous route in IBD patients in REMission.
Nicolas Mathieu, Marianne Hupé, F. Héluwaert, Pauline Rivière +29 more
2025Clinical Gastroenterology and Hepatology9 citations Open access
Semantic Scholar
Therapeutic drug monitoring in inflammatory bowel disease: recent developments
Xavier Roblin, R. Little, Nicolas Mathieu, Stéphane Paul +3 more
2024Expert Review of Gastroenterology & Hepatology9 citations
Semantic Scholar
One‐Year Effectiveness of Upadacitinib in Perianal Crohn's Disease: A Real‐World GETAID Study
Nicolas Richard, P. Seksik, R. Altwegg, M. Nachury +10 more
2026Alimentary Pharmacology and Therapeutics8 citations Open access
Semantic Scholar
Impaired reprogramming of the autophagy flux in maturing dendritic cells from crohn disease patients with core autophagy gene-related polymorphisms
G. Quiniou, L. Andromaque, R. Duclaux-Loras, O. Dinet +8 more
2024Autophagy8 citations Open access
Semantic Scholar
Prevalence of the Oral Corticosteroid Exposure and Excessive Use in Patients with Inflammatory Bowel Disease: Data from Four French Referral Centers of the International DICE Study
S. Nancey, X. Hébuterne, C. Gilletta, Evguenia Hacques +1 more
2024Journal of Clinical Medicine8 citations Open access
Semantic Scholar
Safety comparison of single-donor and pooled fecal microbiota transfer product preparation in ulcerative colitis: systematic review and meta-analysis
B. Laperrousaz, Benoît Levast, Mathieu Fontaine, S. Nancey +3 more
2024BMC Gastroenterology7 citations Open access
Semantic Scholar
Risk of incident cancer in patients with Inflammatory Bowel Disease with prior breast cancer: a multicenter cohort study.
G. Le Cosquer, Julien Kirchgesner, C. G. de Saint Joseph, P. Seksik +25 more
2024Clinical Gastroenterology and Hepatology7 citations Open access
Semantic Scholar
Advances in Understanding Intestinal Homeostasis: Lessons from Inflammatory Bowel Disease and Monogenic Intestinal Disorder Pathogenesis
C. Petit, A. Rozières, Gilles Boschetti, C. Viret +3 more
2025International Journal of Molecular Sciences6 citations Open access
Semantic Scholar
Patient Satisfaction and Experience with CT-P17 Following Transition from Reference Adalimumab or Another Adalimumab Biosimilar: Results from the Real-World YU-MATTER Study
G. Bouguen, L. Gossec, V. Abitbol, E. Senbel +14 more
2024BioDrugs6 citations Open access
Semantic Scholar
Subcutaneous Infliximab for Perianal Crohn's Disease: The BioLap-Rem Multicenter Study From the GETAID
M. André, J. Kirchgesner, D. Laharie, L. Guillo +19 more
2025American Journal of Gastroenterology5 citations Open access
Semantic Scholar
Blood proteomic signatures associated with disease activity in Inflammatory Bowel Diseases.
Maëva Veyssière, Nassim Hammoudi, L. Le Bourhis, D. Hassid +21 more
2025Journal of Crohn's & Colitis5 citations Open access
Semantic Scholar
OP38 Comparative efficacy of infliximab and vedolizumab after failure of a first anti-TNF in patients with ulcerative colitis: a double-blind randomized controlled trial (EFFICACI)
G. B. M.D.-Phd, M. Nachury, S. Nancey, Y. Bouhnik +22 more
2025Journal of Crohn's & Colitis5 citations
Semantic Scholar
The Effectiveness of second-and-third line biologics in perianal Crohn's disease - a multicenter propensity score-matched study.
U. Shani, M. State, R. B. Mateescu, A. Davidoiu +39 more
2025Journal of Crohn's & Colitis5 citations Open access
Semantic Scholar
Impact of histological remission for predicting clinical relapse in Crohn's disease: a post-hoc analysis of the prospective STORI cohort.
C. Reenaers, D. Enea, M. Nachury, D. Laharie +12 more
2024Journal of Crohn's & Colitis5 citations Open access
Semantic Scholar
Ustekinumab for fistulising perianal Crohn's disease: a randomised placebo-controlled trial from the GETAID.
P. Wils, S. Nancey, E. Messmer, A. Bourreille +12 more
2026Gut4 citations
Semantic Scholar
Patient preferences for adalimumab in inflammatory bowel disease: a nationwide study from the GETAID
B. Caron, P. Seksik, A. Buisson, P. Wils +17 more
2024Therapeutic Advances in Gastroenterology4 citations Open access
Semantic Scholar
An audit of central venous catheter insertion and management practices in two French university hospitals
N. Khanafer, Sophie Gardes, Nathalie De-Santis, Céline Liard +8 more
2024European Journal of Clinical Microbiology and Infectious Diseases4 citations Open access
Semantic Scholar
Association between physical activity with disease activity and functional disability in patients with inflammatory bowel disease.
Maud Gendard, P. Seksik, C. Stefanescu, Antoine Meyer +38 more
2026Digestive and Liver Disease3 citations Open access
Semantic Scholar
Uncovering the dynamics of mucosa-associated microbiota in post-operative recurrence of Crohn's disease.
Léonard Dubois, Alexandre Chaussard, P. Seksik, S. Nancey +20 more
2026Gastroenterology3 citations Open access
Semantic Scholar
Deep Characterisation of Circulating Torque Teno Virus DNA Load in Crohn's Disease Patients
Margaux Goens, W. Mouton, G. Oriol, V. Cheynet +9 more
2025Journal of Medical Virology3 citations
Semantic Scholar
P322 Compared Efficacy of Second-Line Treatments for Ulcerative Colitis After Failure of Vedolizumab in First-Line Treatment: A Retrospective Multicenter Study
L. Calméjane, C. Reenaers, A. Amiot, A. Nuzzo +24 more
2024Journal of Crohn's & Colitis3 citations Open access
Semantic Scholar
DOP79 Promising efficacy of biologicals and small molecules for microscopic colitis: results from a large real-life multicenter cohort
B. Verstockt, T. Taelman, S. Vavricka, Y. Zabana +30 more
2024Journal of Crohn's & Colitis3 citations Open access
Semantic Scholar
IL-10-neutralising autoantibodies in paediatric-onset inflammatory bowel disease
Ahmet Yalcinkaya, Ella Sandström, Emma J. DeGrace, B. Pigneur +15 more
2026Gut2 citations Open access
Semantic Scholar
DOP007 Ustekinumab for Fistulizing Perianal Crohn’s Disease: week-48 results from the USTAP Randomized Placebo-ControlledTrial
P. Wils, S. Nancey, E. Messmer, A. Bourreille +11 more
2026Journal of Crohn's & Colitis2 citations
Semantic Scholar
Higher Colonic Tissue Drug Concentrations of Subcutaneous Compared to Intravenous Administration of Infliximab Therapy in Patients With Inflammatory Bowel Disease
X. Roblin, S. Nancey, K. Papamichael, F. Mechi +9 more
2026United European Gastroenterology journal2 citations Open access
Semantic Scholar
Persistence, Safety and Pharmacokinetics of Vedolizumab After Switching to the Subcutaneous Route in a Prospective French National Cohort Study.
Marianne Hupé, Nicolas Mathieu, A. Amiot, P. Seksik +22 more
2026Alimentary Pharmacology and Therapeutics2 citations
Semantic Scholar
Diet and clinical remission in patients with inflammatory bowel disease: A multicenter cross-sectional study.
L. Fontaine, P. Seksik, C. Stefanescu, M. Nachury +38 more
2025Digestive and Liver Disease2 citations Open access
Semantic Scholar
P0362 Bowel urgency in inflammatory bowel disease: The URGENT index
B. Caron, Y. Bouhnik, C. Stefanescu, X. Treton +8 more
2025Journal of Crohn's & Colitis2 citations
Semantic Scholar
P0621 Effectiveness and Safety of Induction Therapy with Upadacitinib for the Treatment of Perianal Crohn’s Disease : Real-World Data from a GETAID Multicentre Cohort Study
N. Richard, R. Altwegg, P. Seksik, S. Nancey +14 more
2025Journal of Crohn's & Colitis2 citations
Semantic Scholar
DOP23 The role of histology for the prediction of clinical relapse in Crohn’s Disease: A substudy of the STORI cohort
C. R. Dr, D. Enea, M. Nachury, D. Laharie +12 more
2024Journal of Crohn's & Colitis2 citations Open access
Semantic Scholar
Post-Discharge Outcomes of Elderly Patients Hospitalized for Inflammatory Bowel Disease Flare Complicated by Clostridioides difficile Infection.
I. Goren, Ortal Fallek Boldes, Tomer Boldes, O. Knyazev +42 more
2024Journal of Crohn's & Colitis2 citations Open access
Semantic Scholar
P0096 ATG16L1 T300A alters autophagosomal cargoes and modulates inflammation in Crohn’s Disease
L. Andromaque, R. Duclaux-Loras, C. Viret, M. Faure +2 more
2026Journal of Crohn's & Colitis1 citations
Semantic Scholar
Subcutaneous vedolizumab dose intensification in inflammatory bowel disease patients: the OPTI-VEDO multicenter study from the GETAID.
P. Wils, R. Altwegg, A. Buisson, L. Vuitton +23 more
2025Journal of Crohn's & Colitis1 citations
Semantic Scholar
P0704 A Multicenter Study Evaluating the Persistence, Effectiveness, and Safety of Methotrexate in Patients with Inflammatory Bowel Disease: The MICI-METHO Study
B. Caron, J. Kirchgesner, M. Nachury, G. Bouguen +17 more
2025Journal of Crohn's & Colitis1 citations
Semantic Scholar
Impact of immediate drug optimization of ustekinumab on medium term targets in Crohn's disease: results from the multicentre retrospective real-life study MUST.
M. Hupé, A. Abdelmoula, T. Chateau, S. Pestour +5 more
2025Digestive and Liver Disease1 citations Open access
Semantic Scholar
Care for peripheral intravenous catheter: an audit in two French university hospitals
Sophie Gardes, Alexandra Pandini, K. Tazarourte, Céline Liard +7 more
2025European Journal of Clinical Microbiology and Infectious Diseases1 citations
Semantic Scholar
Real-world effectiveness of advanced therapies in microscopic colitis.
B. Verstockt, T. Taelman, Shahida Din, S. Vavricka +36 more
2025Clinical Gastroenterology and Hepatology1 citations Open access
Semantic Scholar
P679 Anti-TNF de-escalation following a treat-to-target strategy with golimumab therapy intensification to reach continuous clinical response in ulcerative colitis: the In-Target GETAID trial
L. Vuitton, F. Poullenot, Y. Bouhnik, P. Wils +19 more
2024Journal of Crohn's & Colitis1 citations Open access
Semantic Scholar
P857 Effectiveness and safety of subcutaneous infliximab in perianal Crohn's disease: a multicentre cohort study
M. André, J. Kirchgesner, D. Laharie, L. Guillo +19 more
2024Journal of Crohn's & Colitis1 citations Open access
Semantic Scholar
P927 Long-term outcomes of risankizumab in Crohn’s disease: a multicenter GETAID Study
M. Fumery, B. Caron, X. Hébuterne, R. Altwegg +24 more
2024Journal of Crohn's & Colitis1 citations Open access
Semantic Scholar
Methotrexate and IBD: mechanisms of action, indications/use
S. Nancey, D. Laharie
2024Hépato-Gastro & Oncologie Digestive1 citations
Semantic Scholar
Real-world effectiveness and safety of CT-P13, an infliximab biosimilar, for inflammatory bowel diseases: A prospective national observational cohort study (ReFLECT study).
D. Laharie, Y. Bouhnik, L. Vuitton, A. Biron +6 more
2024Clinics And Research in Hepatology and Gastroenterology1 citations Open access
Semantic Scholar
Development and Validation of a Sexual Quality of Life Score for Youths with Inflammatory Bowel Disease.
A. Mancheron, Agnès Dumas, I. Nion-Larmurier, C. Landman +17 more
2024Journal of Crohn's & Colitis1 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

D. Laharie×25
Invite
D. Laharie — researcher profile on SciRah
M. Fumery×24
Invite
M. Fumery — researcher profile on SciRah
R. Altwegg×21
Invite
R. Altwegg — researcher profile on SciRah
L. Vuitton×21
Invite
L. Vuitton — researcher profile on SciRah

×17

Invite

M. Nachury — researcher profile on SciRah

Invite

A. Buisson — researcher profile on SciRah

Invite

A. Amiot — researcher profile on SciRah

C. Gilletta×12

Invite

C. Gilletta — researcher profile on SciRah

Invite

L. Caillo — researcher profile on SciRah

Invite

P. Wils — researcher profile on SciRah

C. Le Berre×10

Invite

C. Le Berre — researcher profile on SciRah

Invite

E. Vicaut — researcher profile on SciRah